{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:04:51Z","timestamp":1784365491219,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Fungal Biol."],"abstract":"<jats:p>Among critically ill patients, COVID-19-associated pulmonary aspergillosis (CAPA) is a challenging complication. The recommended diagnostic methods for this disease are bronchoalveolar lavage (BAL) culture and galactomannan (GM) testing, which were not widely available during the pandemic. There is scarce information regarding GM testing in other respiratory specimens. Our objective was to compare the agreement of GM between BAL and tracheal aspirate (TA) samples. We selected patients with COVID-19 and those with suspected CAPA who were admitted in the intensive care unit (ICU). GM was routinely done in BAL. We performed GM in TA samples and compared the results. The agreement was evaluated with Cohen's Kappa coefficient. GM was considered positive when an OD index \u2265 1 in BAL and \u2265 2 in TA were found. Probable CAPA was considered when the ECMM\/ISHAM criteria were met. A descriptive analysis of clinical characteristics and mortality was made. We included 20 patients with suspected CAPA from 54 patients with critical COVID-19, of which 5 (9%) met the probable category. <jats:italic>Aspergillus fumigatus<\/jats:italic> was the most frequent isolate. We found moderate agreement between BAL and TA GM (Kappa = 0.47, <jats:italic>p<\/jats:italic> = 0.01, 95% CI.04\u20130.9), whereas TA GM had 75% sensitivity (95% CI 19.4\u201399.4%), 81.2% specificity (95% CI 54.4\u201395.9%), 50% positive predictive value (95% CI 23.8\u201376.3%),] and 92.8% negative predictive value (95% CI 70.1\u201398.6%), and 80% accuracy (95% CI 56.3\u201394.3%). Lastly, three (60%) patients with CAPA died during hospitalization compared to 40% (6\/15) without CAPA (<jats:italic>p<\/jats:italic> = 0.4). In conclusion, a moderate agreement between TA GM and BAL was found. Therefore, TA testing may aid in ruling out CAPA due to high negative predictive value when bronchoscopies are unavailable.<\/jats:p>","DOI":"10.3389\/ffunb.2022.855914","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T06:07:51Z","timestamp":1649398071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis"],"prefix":"10.3389","volume":"3","author":[{"given":"Carla M.","family":"Rom\u00e1n-Montes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00fal","family":"Bojorges-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"D\u00edaz-Lomel\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Cervantes-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rangel-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areli","family":"Mart\u00ednez-Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Sifuentes-Osornio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ponce-de-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Gonz\u00e1lez-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/idr13040093","article-title":"Root causes of fungal coinfections in COVID-19 infected patients","volume":"13","author":"Amin","year":"2021","journal-title":"Infect. Dis. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/lungindia.lungindia_532_21","article-title":"Lower respiratory tract sampling in COVID-19 acute respiratory distress syndrome: A focus on microbiology, cellular morphology, cytology, and management impact","volume":"39","author":"Bansal","year":"2022","journal-title":"Lung India."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","author":"Bassetti","year":"2021","journal-title":"Clini. Infect. Dis. 72"},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","article-title":"Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review","volume":"113","author":"Chong","year":"2021","journal-title":"J. Hosp. Infect."},{"key":"B5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s15010-021-01701-x","article-title":"Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis","volume":"50","author":"Chong","year":"2022","journal-title":"Infection"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jof7121067","article-title":"A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)","author":"Feys","year":"2021","journal-title":"J Fungi."},{"key":"B7","doi-asserted-by":"publisher","first-page":"19342","DOI":"10.1038\/s41598-021-98499-3","article-title":"Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases","volume":"11","author":"Fitzek","year":"2021","journal-title":"Scientific Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcrc.2020.07.002","article-title":"Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series","volume":"59","author":"Flikweert","year":"2020","journal-title":"J. Crit. Care."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: We should be prepared","author":"Gangneux","year":"2020","journal-title":"J Mycol Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir. Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/myc.13259","article-title":"Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate","volume":"64","author":"Grootveld","year":"2021","journal-title":"Mycoses"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2069-y","article-title":"Flexible bronchoscopy-related safety in patients with severe ARDS","author":"Guillon","year":"2018","journal-title":"J. Crit. Care. (London, England)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/emermed-2019-208447","article-title":"Recognising bias in studies of diagnostic tests part 2: interpreting and verifying the index test","volume":"36","author":"Kea","year":"2019","journal-title":"Emerg. Med. J: EMJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"","journal-title":"Lancet Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/myc.13183","article-title":"Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-a simulation study","volume":"64","author":"Koehler","year":"","journal-title":"Mycoses"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238825","article-title":"Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study","author":"Lahmer","year":"2021","journal-title":"PloS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/myc.13213","article-title":"Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity","volume":"64","author":"Machado","year":"2021","journal-title":"Mycoses"},{"key":"B18","unstructured":"\u201cBronchoscopy,\u201d\n            MahmoudN.\n            VashishtR.\n            SanghaviD.\n            KalanjeriS.\n          StatPearls2022"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.02.21250362","article-title":"Bronchoscopy in COVID19 ARDS patients on mechanical ventilation \u2013 a prospective study","author":"Mehta","year":"2021","journal-title":"Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/myc.13292","article-title":"Incidence and mortality of COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"64","author":"Mitaka","year":"2021","journal-title":"Mycoses"},{"key":"B21","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.2021"},{"key":"B22","doi-asserted-by":"publisher","first-page":"173854","DOI":"10.1016\/j.ejphar.2021.173854","article-title":"Dexamethasone: therapeutic potential, risks, and future projection during COVID-19 pandemic","volume":"894","author":"Noreen","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00134-021-06510-2","article-title":"COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges","volume":"47","author":"Prattes","year":"","journal-title":"Intensive Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00134-021-06471-6","article-title":"Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry","volume":"47","year":"","journal-title":"Intensive Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/myc.13216","article-title":"Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis","volume":"64","author":"Roman-Montes","year":"2021","journal-title":"Mycoses"},{"key":"B26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/myc.13328","article-title":"Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis","volume":"64","author":"Singh","year":"2021","journal-title":"Mycoses"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03240-7","article-title":"Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey","author":"Tzotzos","year":"2020","journal-title":"Critical Care (London, England)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.202005-2018LE","article-title":"Detection of invasive pulmonary aspergillosis in COVID-19 with non-directed bronchoalveolar lavage","volume":"202","author":"Van Biesen","year":"2020","journal-title":"Am. J. Respir. Crit."},{"key":"B30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S2213-2600(21)00138-7","article-title":"COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion","volume":"9","author":"van de Veerdonk","year":"2021","journal-title":"Lancet Respir. Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/mmy\/myab009","article-title":"COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City","volume":"59","author":"V\u00e9lez Pintado","year":"2021","journal-title":"Med. Mycol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","article-title":"Diagnosing COVID-19-associated pulmonary aspergillosis","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/LBR.0000000000000681","article-title":"American Association for Bronchology and Interventional Pulmonology (AABIP) statement on the use of bronchoscopy and respiratory specimen collection in patients with suspected or confirmed COVID-19 infection","volume":"27","author":"Wahidi","year":"2020","journal-title":"J. Bronchol. Interv. Pulmonol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med"}],"container-title":["Frontiers in Fungal Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ffunb.2022.855914\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T06:08:05Z","timestamp":1649398085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ffunb.2022.855914\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":35,"alternative-id":["10.3389\/ffunb.2022.855914"],"URL":"https:\/\/doi.org\/10.3389\/ffunb.2022.855914","relation":{},"ISSN":["2673-6128"],"issn-type":[{"value":"2673-6128","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"article-number":"855914"}}